MedTrace Logo

Interaction Between the Vaginal and Seminal Microbiome in Patients With an Altered Vaginal Microbiome Pattern Resistant to Treatment

NCT04641390 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-08-30

No results posted yet for this study

Summary

It,s a retrospective case-control pilot study is to be carried out. Twenty patients will be included in the study for each branch (a total of 60). The study population will be patients whose partners have a diagnosis of an altered vaginal microbiome with (Cases, n = 20) or without (Controls, n = 20) persistence to drug treatment. Since a normal reference seminal microbiome has not been described, we will include a control group that will consist of sperm donors (n = 20) who are considered fertile potential without reproductive problems.

The main objective of the project is to identify the interaction of the vaginal and seminal microbiome patterns in couples in which the vaginal pattern is altered and is persistent to drug treatment.

Conditions

  • Fertility Disorders

Interventions

OTHER

Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome resistant to drug treatment

The analysis of the seminal microbiome will be carried out by massive genetic sequencing

OTHER

Analysis of the seminal microbiome of the partners of women with altered vaginal microbiome not resistant to drug treatment

The analysis of the seminal microbiome will be carried out by massive genetic sequencing

Sponsors & Collaborators

  • Instituto Bernabeu

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-12-15
Completion
2022-04-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04641390 on ClinicalTrials.gov